PETALING JAYA: Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp) is targeting five potential BioNexus status companies to go for listing in the next two to five years. BiotechCorp CEO Datuk Mohd Nazlee Kamal said a listing of bio-based companies on Bursa Malaysia would strengthen Malaysia's presence in the bio-based industry and reinforce the country's market position in the Asia Pacific region, not to mention that it will also help to further develop local bio-based companies. The IPO can act as a platform for companies to access the capital market for fund raising and enhance their profile and visibility and he hope to see more bio-based companies listed on Bursa Malaysia. "In gauging the potential for the sector, the performance of BioNexus status companies have been encouraging. As at December 2014, the investment made and revenue generated by BioNexus status companies are approximately RM3 billion and RM1.3 billion respectively. We are targeting 5 potential BioNexus status companies to go for listing in the next 2 to 5 years," Mohd Nazlee said. Meanwhile, Bursa Malaysia CEO Datuk Tajuddin Atan said currently, there are over 903 companies representing 60 economic activities listed on Bursa Malaysia. "In addition to the market place's sector leadership in areas such as palm oil, oil and gas, logistics and banking, our public listed companies (PLCs) are indeed among the best in the world," he said. This, he said, is evidenced by the latest Forbes Annual Global 2000 ranking of the world's biggest and most powerful PLCs which saw 16 Malaysian firms in the list. Yesterday, Bursa Malaysia hosted an IPO sharing session for participants from the BioNexus status and Bio-economy group of companies. The event was organised in collaboration with BiotechCorp with the aim of providing owners and entrepreneurs of those companies, a better understanding and appreciation of the benefits of listing on Bursa Malaysia as well as the process involved.